for

Press Release: Sanofis Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy…

3 months ago

ACTFORE Secures Patent for Template Identification and Matching Technology, Transforming Large-Scale Document Analysis in Breach Response

RESTON. Va., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ACTFORE, a leading provider of AI-powered breach response and data mining solutions,…

3 months ago

Star Health reports 414% YoY Ind AS Profit growth to 449 Cr for Q3 FY26

Q3 Combined Ratio improves 317 bps to 98.9% driven by Loss Ratio moderationCHENNAI, India, Jan. 30, 2026 /PRNewswire/ -- Star Health…

3 months ago

Delinea Receives Frost & Sullivan’s 2026 Global Technology Innovation Leadership Recognition for Innovation in Non-Human Identity Security

Delinea is recognized for its technology innovation, market leadership, and customer-centric approach to securing non-human identities through AI-driven, unified identity…

3 months ago

Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology-Healthcare Informatics

Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informaticsSAN ANTONIO,…

3 months ago

Haber Receives Frost & Sullivan’s 2025 Global Technology Innovation Leadership Recognition for Industrial AI

The recognition acknowledges Haber's leadership in AI-driven process control, industrial AI, and measurable industrial performance outcomes.SAN ANTONIO, Jan. 29, 2026 /PRNewswire/…

3 months ago

Esports World Cup Foundation Confirms $45 Million Commitment to Players, Clubs and National Teams for Inaugural Esports Nations Cup 2026

ENC to elevate global esports by establishing a structured national ecosystem that supports players, Clubs, and National Teams — backed…

3 months ago

QTX-2101 Awarded FDA Fast Track Designation for the Treatment of Acute Promyelocytic Leukemia

CHICAGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing treatments for rare diseases, announced…

3 months ago

ALK receives positive recommendation for EURneffy 1 mg: A needle-free anaphylaxis treatment for children

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Committee for Medicinal Products for Human Use (‘CHMP’)…

3 months ago

NYSE Content Advisory: Pre-Market Update + First Lady Melania Trump to Ring NYSE Bell for Doc ‘Melania’

NEW YORK, Jan. 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

3 months ago